Kong et al recently showed that hypomethylation in a specific CD147/BSG promoter region, comprising SP1 binding sites, leads to upregulation of CD147 expression and is associated with poor prognosis in HCC [15]. The gene discussed is SP1; the disease is hepatocellular carcinoma.